From: BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Mean age | 52.2 years |
---|---|
Age range | 21-87 years |
Age distribution | Â |
   ≤40 years | 24 (13.6%) |
   41-60 years | 104 (58.8%) |
   ≥61 years | 48 (27.1%) |
   Non-informative | 1 (0.6%) |
T status | |
   T = 1 | 24 (13.6%) |
   T>1 | 151 (85.3%) |
   Non-informative | 2 (1.1%) |
N status | |
   N = 0 | 61 (34.5%) |
   N = 1 | 44 (24.9%) |
   Nx | 70 (39.5%) |
   Non-informative | 2 (1.1%) |
Tumour differentiation | |
   Grade 1 | 19 (10.7%) |
   Grade 2 | 47 (26.6%) |
   Grade 3 | 94 (53.1%) |
   Non-informative | 17 (9.6%%) |
Histology | |
   Serous adenocarcinoma | 144 (81.4%) |
   Mucinous adenocarcinoma | 6 (3.4%) |
   Adenocarcinoma, unspecified | 21 (11.9%) |
   Other | 6 (3.4%) |
Total | 177 (100%) |